Possibilities of using sodium hyaluronate in pharmaceutical and medical fields
Authors:
Veronika Pechová; Jan Gajdziok
Published in the journal:
Čes. slov. Farm., 2017; 66, 154-159
Category:
Review Articles
Summary
Sodium hyaluronate represents a contemporary biomaterial with broad use in different pharmaceutical and medical fields. It is a physiological glycosaminoglycan, which occurs primarily in the extracellular matrix, synovial fluid, cartilage, epidermis and vitreous body. It plays a critical role as a signalling molecule in immunological processes, cell motility and wound healing, and it possesses antioxidant activity. It is used in many fields of medicine if supplementation of hyaluronan is needed or in the cases of preventive and therapeutic interventions. Thanks to its moisturizing, regenerative and protective effects it is used in cosmetics as well.
Key words:
sodium hyaluronate • hyaluronic acid • hyaluronan • derivatives of sodium hyaluronate • dosage forms • medicinal use
Zdroje
1. Ministerstvo zdravotnictví ČR. Český lékopis 2009. 1. vydání. Praha: Grada Publishing 2009.
2. Balazs E. A., Laurent T. C., Jeanloz R. W. Nomenclature of hyaluronic acid. Biochem. J. 1986; 235, 903.
3. Schiller J., Volpi N., Hrabárová E., Šoltés L. Hyaluronic acid: A natural biopolymer. In: Kalia S., Avérous L. (eds.) Biopolymers: Biomedical and environmental applications. Hoboken: John Wiley and Sons 2011.
4. Sosnik A., das Neves J., Sarmento B. Mucoadhesive polymers in the design of nanodrug delivery systems for administration by non-parenteral routes: A review. Prog. Polym. Sci. 2014; 39, 2030–2075.
5. Volpi N., Schiller J., Stern R., Soltés L. Role, metabolism, chemical modifications and applications of hyaluronan. Curr. Med. Chem. 2009; 16, 1718–1745.
6. Slíva J., Minárik J. Hyaluronát – nejen pasivní pozorovatel, nýbrž aktivní modulátor imunitních reakcí. New EU Magazine of Medicine. 2009; 1–2, 75–79.
7. Fraser J. R., Laurent T. C., Laurent U. B. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 1997; 242, 27–33.
8. Laurent T. C., Laurent U. B. G., Fraser J. R. E. The structure and function of hyaluronan: An overview. Immunol. Cell Biol. 1996; 74, A1–A7.
9. Hašová M., Crhák T., Safránková B., Dvořáková J., Muthný T., Velebný V., Kubala L. Hyaluronan minimizes effects of UV irradiation on human keratinocytes. Arch. Dermatol. Res. 2011; 303, 277–284.
10. Meyer K., Palmer J. W. The polysaccharide of the vitreous humor. J. Biol. Chem. 1934; 107, 629–634.
11. Necas J., Bartosikova L, Brauner P., Kolar J. Hyaluronic acid (hyaluronan): a review. Vet. Med. 2008; 53, 397–411.
12. Long F. D., Adams R. G., DeVore D. P. Preparation of hyaluronic acid from eggshell membrane. US Patent No. 6946551; 2005.
13. Contipro. Hyaluronic acid. https://www.contipro.com/images/ProductLists/Hyaluronic-Acid_Contipro.pdf (29. 6. 2017).
14. Schiraldi Ch., La Gatta A., de Rosa M. Biotechnological Production and Application of Hyaluronan. In: Elnashar M. eds. Biopolymers. Rijeka: Intech 2010.
15. Larsen N. E., Balazs E. A. Drug delivery systems using hyaluronan and its derivatives. Adv. Drug Delivery Rev. 1991; 7, 279–293.
16. Šedová P., Buffa R., Kettou S., Huerta-Angeles G., Hermannová M., Leierová V., Šmejkalová D., Moravcová M., Velebný V. Preparation of hyaluronan polyaldehyde-a precursor of biopolymer conjugates. Carbohydr. Res. 2013; 371, 8–15.
17. Uhart M., Pirot F., Boillon A., Senaux E., Tall L., Diouf E., Burillon C., Padois K., Falson F., Leboucher G., Pivot C. Assessment of sodium hyaluronate gel as vehicle for intracameral delivery of cefuroxime in endophthalmitis prophylaxis. Int. J. Pharm. 2010; 398, 14–20.
18. Kuchynka P. Oční lékařství. 2., přepracované a doplněné vydání. Praha: Grada Publishing 2016.
19. Arshinoff S. A. Dispersive-cohesive viscoelastic soft shell technique. J. Cataract. Refract. Surg. 1999; 25, 167–173.
20. Nepp J., Schauersberger J., Schild G., Jandrasits K., Haslinger-Akramian J., Derbolav A., Wedrich A. The clinical use of viscoelastic artificial tears and sodium chloride in dry-eye syndrome. Biomaterials. 2001; 22, 3305–3310.
21. Varcholová D. Současné možnosti v substituční terapii syndromu suchého oka. Remedia 2006; 5, 2006, 503–508.
22. Odehnal M., Ferrová K., Malec J. Léčba suchého oka – Poruchy slzných žláz, slzného filmu a využití umělých slz v praxi. Praktické lékárenství 2010; 6, 149–152.
23. Messmer E. M. Konservierungsmittel in der Ophthalmologie. Ophthalmologie 2012; 109, 1064–1070.
24. Ursapharm. COMOD®-systém. http://ursapharm.cz/cz/vyroba-systemy/comod-system/ (29. 6. 2017).
25. Théa. ABAK Pure technology in a bottle. http://www.laboratoires-thea.com/medias/abak_brochure_eng.pdf (29. 6. 2017).
26. Engström-Laurent A. Hyaluronan in joint disease (Minisymposium: Hyaluronan). J. Intern. Med. 1997; 242, 57–60.
27. Akmal M., Singh A., Anand A., Kesani A., Aslam N., Goodship A., Bentley G. The effects of hyaluronic acid on articular chondrocytes. J. Bone Jt. Surg. Br. Vol. 2005; 87, 1143–1149.
28. Trč T. Současný stav viskosuplementace v léčbě osteoartrózy. Farmakoterapie 2012; 8, 608–611.
29. Butler J., Rydell N. W., Balazs E. A. Hyaluronic acid in synovial fluid. VI. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of arthritis in track horses. Acta Vet. Scand. 1970; 11, 139–155.
30. Frei R. Viskosuplementace v léčbě osteoartrózy. Farmakoterapie v praxi (ortopedie, revmatologie) 2014; 5, 3–6.
31. Contipro. Nutrihyl®. http://www.aktivnizvire.cz/hyaluronan-pro-klouby (29. 6. 2017).
32. Balogh L., Polyak A., Mathe D., Kiraly R., Thuroczy J., Terez M., Janoki G., Ting Y., Bucci L. R., Schauss A. G. Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs. J. Agric. Food Chem. 2008; 56, 10582–10593.
33. Sahbaz A., Aynioglu O., Isik H., Ozmen U., Cengil O., Gun B. D., Gungorduk K. Bromelain: A natural proteolytic for intra-abdominal adhesion prevention. Int. J. Surg. 2015; 14, 7–11.
34. Matěna O. Antiadhezivní prostředky v laparoskopické operativě. Prakt. Gyn. 2013; 17, 237–240.
35. Křižan V., Pánková S., Hudeček R. Význam hyaluronátu v gynekologii a porodnictví. Prakt. Gyn. 2012; 16, 7–12.
36. Pánková S., Hudeček R., Račanská E. Peroperační prevence adhezí v gynekologii. Prakt. Gyn. 2009; 13, 70–75.
37. Huang H., Deng M., Jin H., Dirsch O., Dahmen U. Preventing intra-abdominal adhesions with a sodium hyaluronate carboxymethylcellulose membrane enabled visualization of hepatic microcirculation. Int. J. Surg. 2013; 11, 935–943.
38. Juhlin L. Hyaluronan in skin. J. Intern. Med. 1997; 242, 61–66.
39. Borzacchiello A., Russo L., Malle B. M., Schwach-Abdellaoui K., Ambrosio, L. Hyaluronic acid based hydrogels for regenerative medicine applications. BioMed Research International 2015; 2015, 1–12.
40. Dicker K. T., Gurski L. A., Pradhan-Bhatt S., Witt R. L., Farach-Carson M. C., Jia X. Hyaluronan: A simple polysaccharide with diverse biological functions. Acta Biomater. 2014; 10, 1558–1570.
41. Hyiodine®. Příručka k aplikaci. https://www.hyiodine.cz/images/Brochures/hyodine_%20prirucka_k_aplikaci.pdf (29. 6. 2017).
42. SÚKL. Databáze léků. http://www.sukl.cz/modules/medication/search.php (29. 6. 2017).
43. Buchsel P. C. Polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair): a bioadherent oral gel for the treatment of oral mucositis and other painful oral lesions. Expert Opin. Drug Metab. Toxicol. 2008; 4, 1449–1454.
44. Gelclair®. Bioadherent oral rinse gel for effective relief of pain associated with oral mucositis. http://www.gelclair.com/ (29. 6. 2017).
45. Trud™. A new treatment for ulcerative colitis. http://www.treatwithtrud.com/-EN- (29. 6. 2017).
46. Bortlík M. Hyaluronát sodný: nová cesta v léčbě ulcerózní kolitidy? Gastroent. Hepatol. 2014; 68, 468–469.
47. Hysan® Care sprej. Návod k použití. http://www.nosnipece.cz/sites/default/files/PB%20HYSAN%20Pfl%20CZ_SK%2090.1656.pdf (29. 6. 2017).
48. Rejchrt M., Havlová K., Kříž J. Prevence recidivujících uroinfekcí intravezikální instilací kyseliny hyaluronové a chondroitinsulfátu u pacientů po míšním poranění. Urol. praxi 2015; 16, 43.
49. Romžová M. Možné příčiny vzniku inkontinence a jejich řešení. Urol. praxi 2014; 15, 221–226.
50. Papakonstantinou E., Roth M., Karakiulakis G. Hyaluronic acid: A key molecule in skin aging. Dermatoendocrinol. 2012; 4, 253–258.
51. Trommer H., Wartewig S., Bötcher R., Pöppl A., Hoentsch J., Ozegowski J. H., Neubert R. H. The effects of hyaluronan and its fragments on lipid models exposed to UV irradiation. Int. J. Pharm. 2003; 254, 223–234.
52. Baspeyras M., Rouvrais C., Liégard L., Delalleau A., Letellier S., Bacle I., Courrech L., Murat P., Mengeaud V., Schmitt A. M. Clinical and biometrological efficacy of a hyaluronic acid-based mesotherapy product: A randomised controlled study. Arch. Dermatol. Res. 2013; 305, 673–682.
53. Dick H. B., Schwenn O. Viscoelastics in Ophthalmic Surgery. 1. vydání. Berlín: Springer 2000.
54. Hyabak®. Preservative-free Sodium Hyaluronate dry eye drops. http://www.thea-pharmaceuticals.co.uk/products/hyabak (29. 6. 2017).
55. Ursapharm. Hylo® Eye Care. http://ursapharm.cz/cz/produkty/zdravotnicke-prostredky/hylo-eye-care/ (29. 6. 2017).
56. Drug Reference Encyclopedia. Orthovisc. http://www.theodora.com/drugs/orthovisc_injection_depuy_mitek.html (29. 7. 2016).
57. Sinovial®. Návod k použití. http://www.ibi.cz/download/Sinovial_navod_k_pouziti.pdf (29. 7. 2016).
58. Dacom® Pharma. Hyalfit®. https://www.dacom.cz/klouby-a-kosti/0-hyalfit-kolagen-kyselina-hyaluronova-kapsle.html (29. 6. 2017).
59. Silvita. Hyalgel. http://www.hyalgel.cz/hyalgel/eshop/1-1-Hyalgel (29. 6. 2017).
Štítky
Addictology Clinical biochemistry Paediatric clinical oncology Paediatric psychiatry Diabetology Endocrinology Pharmacy Clinical pharmacology Intensive Care Medicine Internal medicine General practitioner for children and adolescents General practitioner for adults Psychiatry Toxicology Pharmaceutical assistantČlánok vyšiel v časopise
Czech and Slovak Pharmacy
2017 Číslo 4
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Memantine Eases Daily Life for Patients and Caregivers
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Spasmolytic Effect of Metamizole
Najčítanejšie v tomto čísle
- Possibilities of using sodium hyaluronate in pharmaceutical and medical fields
- Specifics of some calcium salts in intravenous therapy of hypocalcemia and their further use
- Synergistic effect of azole antimycotics (clotrimazole and fluconazole) and natural substances
- Cholinesterase activity assays and their use in the diagnosis of various pathological states including poisoning by neurotoxic agents